Fluorocholine PET/CT in Patients with Prostate Cancer: Initial Experience
- 1 May 2005
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 235 (2), 623-628
- https://doi.org/10.1148/radiol.2352040494
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Kinetics of [ 11 C]choline uptake in prostate cancer: a PET stydyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Value of [ 11 C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [ 18 F]fluorodeoxyglucose-Positron Emission TomographyJournal of Urology, 2003
- Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRSJournal of Neuro-Oncology, 2003
- Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancerUrology, 2001
- Lymph node size does not correlate with the presence of prostate cancer metastasisUrology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical ProstatectomyEuropean Urology, 1999
- Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigenWorld Journal of Urology, 1997
- Metabolic Imaging of Untreated Prostate Cancer by Positron Emission Tomography with sup 18 Fluorine-Labeled DeoxyglucoseJournal of Urology, 1996
- Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: Implications of RTOG data for patient management and trial design and stratificationInternational Journal of Radiation Oncology*Biology*Physics, 1992